Martina Flammer, M.D., currently holds the position of Chief Medical Officer at Insmed Incorporated (INSMED INC), a global biopharmaceutical company focused on developing and commercializing therapies for patients with rare diseases. Dr. Flammer brings a wealth of experience and expertise to her role, having spent over two decades in the pharmaceutical industry. Prior to joining Insmed, she held several senior leadership positions at prominent companies, including serving as the Senior Vice President and Head of Global Medical Affairs at Actelion Pharmaceuticals, where she played a pivotal role in the successful development and launch of multiple products. Dr. Flammer's professional journey is marked by her dedication to advancing medical science and improving patient outcomes. She earned her medical degree from the University of Zurich and completed her residency in internal medicine at the University Hospital Zurich. Throughout her career, Dr. Flammer has demonstrated a strong commitment to clinical research, having authored numerous publications in peer-reviewed journals and presented at various international conferences. Her leadership and strategic vision have been instrumental in guiding the development and execution of clinical programs, particularly in the fields of pulmonology and rare diseases. As Chief Medical Officer at Insmed, Dr. Flammer oversees the company's global medical affairs, clinical development, and pharmacovigilance functions. In this role, she is responsible for shaping the company's clinical strategy and ensuring the successful execution of its pipeline programs. Dr. Flammer's expertise and leadership have been crucial in advancing Insmed's mission to transform the lives of patients with serious and rare diseases. Her contributions have helped to position the company as a leader in the development of innovative therapies, and her ongoing commitment to excellence continues to drive Insmed's success in the biopharmaceutical industry.